ACADIA Pharmaceuticals Inc. ACAD
ACAD
ACADIA Pharmaceuticals Inc. ADMA
ADMA Biologics, Inc. ALKS
Alkermes plc BVNKF
Bavarian Nordic A/S CPRX
Catalyst Pharmaceuticals, Inc. BRCTF
BioArctic AB (publ) NURPF
Neuren Pharmaceuticals Limited AKRO
Akero Therapeutics, Inc. VKTX
Viking Therapeutics, Inc. SRRK
Scholar Rock Holding Corporation
ACADIA Pharmaceuticals Inc. ADMA
ADMA Biologics, Inc. ALKS
Alkermes plc BVNKF
Bavarian Nordic A/S CPRX
Catalyst Pharmaceuticals, Inc. BRCTF
BioArctic AB (publ) NURPF
Neuren Pharmaceuticals Limited AKRO
Akero Therapeutics, Inc. VKTX
Viking Therapeutics, Inc. SRRK
Scholar Rock Holding Corporation
Performance
| Periode | ACAD | ADMA | ALKS | BVNKF | CPRX | BRCTF | NURPF | AKRO | VKTX | SRRK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 37.59 % | -25.05 % | 15.59 % | 60.04 % | -7.66 % | 84.47 % | 93.93 % | 51.05 % | 51.04 % | 40.93 % |
| YTD | 7.50 % | -19.09 % | 8.56 % | 33.27 % | -5.39 % | 67.34 % | 95.46 % | 91.88 % | -18.39 % | -10.64 % |
| 1Y | 33.82 % | -11.18 % | 7.44 % | 16.42 % | -1.36 % | 101.46 % | 123.85 % | 79.54 % | -49.00 % | 38.36 % |
| 3Y | 28.18 % | 472.44 % | 40.71 % | 35.02 % | 64.19 % | 9.66 % | 236.28 % | 37.69 % | 1 007.59 % | 431.81 % |
| 5Y | -53.48 % | 500.83 % | 78.04 % | 7.49 % | 532.30 % | 9.66 % | 1 749.56 % | 86.24 % | 455.63 % | 162.19 % |
| 10Y | -38.86 % | 55.34 % | -47.16 % | -8.25 % | 552.56 % | 9.66 % | -50.68 % | 194.10 % | 388.50 % | 154.58 % |
| From the beginning | 199.40 % | 70.06 % | 467.45 % | 3.92 % | 233.77 % | 9.66 % | -88.79 % | 194.10 % | 319.50 % | 154.58 % |